Infinite Roots sells mushrooms in over 1,000 stores while its mycelium waits on Brussels

In a market where most mycelium start-ups still strive to put products on markets Infinite Roots is building shelf space with ordinary mushrooms while its core technology waits for regulators.
Too long to read? Go for the highlights below.
Infinite Roots has launched a button-mushroom Umami Block, taking its MushRoots range to more than 1,000 stores in Germany and Austria.
The block contains no mycelium, so it needs no EU novel food approval, unlike the fermentation technology the company was founded on.
Meati raised nearly $450m and agreed a $4m sale, while the first EU mycelium approval took six years, so selling a conventional ingredient first is the cheaper route.
Infinite Roots, a Hamburg fermentation start-up, has added an Umami Block made from button mushrooms to its MushRoots range. The range is now in more than 1,000 Rewe stores across Germany and Austria. The block contains no mycelium, and that is the point. The company is building a category on conventional food while the technology it was founded on waits for regulators.

Mushrooms first
The block is deliberately plain. It is 45 per cent button mushroom, bound with wheat and potato protein, and carries 18g of protein per 100g. It joins mince, meatballs and burgers that launched in over 500 Rewe Nord stores, a launch to which Rewe Group also contributed as an investor.

The plainness is a regulatory choice. The EU Novel Food Regulation requires a complex approval process for foods not common before 1997, and MushRoots uses only the above-ground mushroom body, so it does not apply. Mycelium is different. It is the root-like network Infinite Roots grows in fermentation tanks.
Infinite Roots reckons its short label is what won over Rewe's category buyers. That argument is weaker for the block, whose ingredient list runs to more than a dozen items, from potato protein to psyllium husk.
In 2024, just after AgFunder reported its $58m Series B, the company was still in talks with EU regulators while arguing that mycelium from edible mushroom varieties is not a novel food. It now says its fermentation products will follow only once EU novel food approval is through. It has also withdrawn its US safety filing to update its dossier.
Crowded tanks
Meati shows the cost of doing it the other way round. The Colorado mycelium-meat maker raised nearly $450m and was then slated to sell for $4m in 2025, two months after its primary lender pulled nearly two-thirds of its available cash. Building capacity ahead of margin was fatal. Infinite Roots, which uses contract manufacturers, has avoided that exposure. Selling a conventional ingredient first is the better order of operations.
Quorn, the incumbent, shows how thin the prize is even with approval. Monde Nissin bought Quorn's parent, Marlow Foods, for $831m in late 2015. The protein business's first-half 2026 revenue was ₱7.38bn ($120m), up 2.2 per cent. The UK made up 79.1 per cent of its meat alternatives sales in 2025.
Others are making the same turn. Infinite Roots took its mycelium to South Korea in 2024 through its earlier South Korea launch with Pulmuone. In the US, Mushroom Squared's pivot to minimally processed patties follows the same logic of moving away from mimics.

Consumer acceptance
Demand for whole-food proteins is real. In Germany alone, sales of tofu, tempeh and seitan rose 29 per cent last year, against 0.2 per cent for meat alternatives, Green Queen reports. GFI Europe's Circana-based data agrees on the direction. German plant-based meat sales levelled off at €751m in 2025, while volume fell 1.7 per cent. A mushroom block fits that shift better than a meat mimic does.

What comes next
The mycelium route is open but slow. The Protein Brewery's Fermotein, the first mycelium ingredient approved for EU sale, took six years from dossier to authorisation. GFI Europe called the milestone genuine but "a very long time coming". The precedent shows that a dossier can pass. Infinite Roots has given no date for its own decision. Its stated priorities for the next 12 months are to advance mycelium technology and to establish MushRoots as a mushroom category.
The sector is sorting into firms that sell what the law already allows and firms that wait for a ruling. Tanks are the cheap part. Meati's twelve 25,000-litre fermenters reportedly sold for just $75,000Â this year. A cleared route to market and a shelf are scarce. Infinite Roots holds the shelf and is waiting for the route. The companies that end up holding both will be the ones that buy the rest.




